stockrowElevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.
- Revenue
- +1.42%
- EPS
- +17.9%
- Free cash flow
- +29.0%
- Total debt
- −3.65%
Quarter to September 2026, against a year earlier
Follow ELV
Alert me
Elevance Health, Inc. (ELV) EPS (diluted)
Elevance Health, Inc.'s EPS (diluted) for fiscal 2025 was $25.21, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $23.45. Over the past ten years it has ranged from $9.21 (fiscal 2016) to $25.68 (fiscal 2024); the current reading is higher than 82% of that period. Elevance Health, Inc. ranks 2nd of 12 Healthcare Plans companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $25.21 | (1.83%) |
| FY2024 | $25.68 | 1.82% |
| FY2023 | $25.22 | 1.65% |
| FY2022 | $24.81 | 0.32% |
| FY2021 | $24.73 | 37.54% |
| FY2020 | $17.98 | (2.65%) |
| FY2019 | $18.47 | 30.16% |
| FY2018 | $14.19 | (1.11%) |
| FY2017 | $14.35 | 55.81% |
| FY2016 | $9.21 | (1.81%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $6.27 | (6.56%) |
| Jun 2026 | $6.71 | (16.12%) |
| Mar 2026 | $8.00 | 223.89% |
| Dec 2025 | $2.47 | (53.57%) |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CI Cigna Group compare | $24.17 |
| ELV Elevance Health, Inc. | $23.45 |
| UNH UnitedHealth Group Incorporated compare | $17.51 |
| HUM Humana Inc. compare | $10.57 |
| CVS CVS Health Corporation compare | $3.78 |
| CNC Centene Corporation compare | $2.93 |
| OSCR Oscar Health, Inc. compare | $1.40 |
| CLOV Clover Health Investments, Corp. compare | −$0.05 |
| MOH Molina Healthcare, Inc compare | −$0.96 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on ELV
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement